List/Grid

AirJoule Technologies to Form Strategic Partnership with TenX Investment for Exclusive Middle East Distribution

RONAN, Mont, Feb. 02, 2026 (GLOBE NEWSWIRE) — AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading technology platform that unleashes the power of water from air, today announced an agreement with... More >>

سنترال باتانا تستثمر 500 مليون بات في احتفالات العدّ التنازلي في سنترال وورلد بانكوك 2026

بانكوك, Feb. 02, 2026 (GLOBE NEWSWIRE) —

أطلقت شركة سنترال... More >>

Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment

Press Release

Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment

Middle East, February 2,... More >>

EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness

JOHANNESBURG, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security landscape with its pioneering technologies, reinvents a familiar favorite with the debut of its 4G & Wi–Fi battery camera family. By... More >>

BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet

MELBOURNE, Australia, Feb. 01, 2026 (GLOBE NEWSWIRE) — BHP has selected 10 early–stage exploration and technology companies for the 2026 BHP Xplor program, marking the largest cohort since the program began and its fourth year of operation.

The... More >>

Kyowa Kirin Recupera Controle do Programa de Desenvolvimento e Comercialização do Rocatinlimab, Demonstrando Forte Compromisso para Abordar a Alta Necessidade Médica Não Atendida na Dermatite Atópica

  • A Kyowa Kirin afirma o compromisso de desenvolver o rocatinlimab como um ativo diferenciado de mudança de vida com potencial de mercado significativo.
  • More >>

Kyowa Kirin reprend le contrôle du programme de développement et de commercialisation du rocatinlimab, manifestant ainsi son profond engagement visant à répondre aux besoins médicaux non satisfaits dans le domaine de la dermatite atopique

  • Kyowa Kirin réaffirme sa volonté de développer le rocatinlimab comme un traitement innovant capable d’améliorer significativement la vie des patients, tout en offrant un fort potentiel... More >>

Kyowa Kirin erlangt Kontrolle über Entwicklungs- und Kommerzialisierungsprogramm für Rocatinlimab wieder, zeigt starkes Engagement im Bereich des ungedeckten medizinischen Bedarfs bei atopischer Dermatitis

  • Kyowa Kirin bestätigt Engagement für die Entwicklung von Rocatinlimab als lebensveränderndes differenziertes Feld mit bedeutendem Marktpotenzial.
  • More >>